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Summary
Repeated measures of biomarkers have the potential of explaining hazards of sur-
vival outcomes. In practice, these measurements are intermittently measured and are
known to be subject to substantial measurement error. Joint modelling of longitu-
dinal and survival data enables us to associate intermittently measured error-prone
biomarkers with risks of survival outcomes. Most of the joint models available in
the literature have been built on the Gaussian assumption. This makes them sensi-
tive to outliers. In this work, we study a range of robust models to address this issue.
For medical data, it has been observed that outliers might occur with different fre-
quencies over time. To address this, a new model with a time varying robustness is
introduced. Through both a simulation study and analysis of two real-life data exam-
ples, this research not only stresses the need to account for longitudinal outliers in
joint modelling research but also highlights the bias and inefficiency from not prop-
erly estimating the degrees-of-freedom parameter. Each technique presented in this
work can be fitted using the R package robjm.
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1 INTRODUCTION
Biomarkers are used as proxies of one’s health, and are known to be subject to substantial measurement error, due to biological
and non-biological sources. In prospective studies, the biomarkers are repeatedly measured. These measurements are made at
intermittent time-points in practice rather than continuously, and times elapsed between successive measurements are typically
unequal. It is of scientific interest to explain risks of survival outcomes by repeated measures of biomarker data. Two main
obstacles are the intermittent nature of the biomarker data and inherent measurement error. Joint modelling of longitudinal and
survival outcomes enables us to associate repeated measures of biomarkers with the risks of survival events, while taking into
account the aforementioned obstacles. The framework typically combines two sub-models, a mixed-effects model for repeated
measures, and a Cox model for survival data. The sub-models are linked with shared parameters. Reviews of relevant literature
can be found in Tsiatis and Davidian 1 , Diggle, Sousa and Chetwynd 2 , Rizopoulos 3 , McCrink, Marshall and Cairns 4 , Asar et
al. 5 and Elashoff 6 .
A prevailing assumption in the literature is that both random-effects and error terms in the mixed-effects sub-model follow
Normal distributions. However, in most real-life problems, the data-sets include outliers for which the Normal assumption might
be inadequate. Specifically, in prospective studies, two types of outliers may be present:
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2 McFetridge ET AL
i) b-outliers: Outlying individuals within the population that do not conform to population trends. These are outliers within
the longitudinal random-effects.
ii) e-outliers: Outlying observations within an individual’s set of measurements that do not follow the individual’s own trend
over time. These are outliers within the longitudinal random error.
Only in recent years have studies been undertaken to investigate the negative impacts that the presence of longitudinal outliers
under the Normal assumption can have7,8,9,10,11. Robust joint models replace the Normality assumption with t-distributional
assumptions for the random terms. In doing so, the heavier tails down-weigh the detrimental impact of longitudinal outliers
within the joint modelling framework. Initial research on robust joint modelling considered only the 푒-outliers7,8,12, and both 푒-
and 푏-outliers10,11,13,14. Each of these studies found that the parameter estimates and corresponding standard errors are sensitive
to the Normality assumptions when outliers are present, with t-distributional assumptions alleviating such bias. If utilised when
outliers are not present, unbiased estimates are obtained, though Li, Elashoff and Li 7 and Huang, Li and Elashoff 8 noted that the
robust joint models give slightly higher standard errors for the longitudinal parameters. This initial work however restrictively
fixes the degrees-of-freedom at a constant chosen by the user, an assumption alleviated by Baghfalaki, Ganjali and Berridge 9 ,
Asar, Fournier and Dantan 11 and Baghfalaki, Ganjali and Hashemi 14 , who utilised Bayesian approaches, and McCrink 10 ,
who utilised a frequentist approach, to allow estimation of the degrees-of-freedom to be dictated by the data. With estimated
degrees-of-freedom, the t-distributional assumptions of the robust joint model will approximate normality in the absence of
outliers.
All of the aforementioned research, however, assumes that the degrees-of-freedom is constant, unchanging over time, an
assumption prevalent in the literature for robust mixed models alongside their robust joint model counterparts. To address this
issue, we propose a robust joint model which can account for the situation where the impact of outliers can change over time.
Varying frequency of outliers is a very likely scenario, for example, when patients are given new treatments, they typically take
time to stabilise and adjust to these treatments. This period of adjustment means that they are more prone to demonstrating
responses which outlie from the expected and thus the patients’ measurements may not be consistent with the population average
and change over time as they grow accustomed to the new treatments. Incorrectly modelling such scenarios limits our ability to
fully decipher the relationship between how patientsâĂŹ responses change over time and the impact this has on their risk of an
adverse event.
This work explores two examples, one on dialysis, and another on liver cirrhosis. The first example analyses the haemoglobin
levels of Northern Ireland (NI) renal patients after commencing haemodialysis treatment. The second example, utilising theMayo
Clinic Primary Biliary Cirrhosis data-set, analyses data obtained from patients with primary biliary cirrhosis who participated
in a randomized placebo controlled trial of the drug D-penicillamine. In both case studies, it is reasonable to assume that patients
may take time to adjust to the new treatments and thus would be more prone to outlying responses.
A more detailed discussion on the two motivational examples is given in Section 2. The rest of this paper is organised as
follows. In Section 3, themethodology for the various joint modelling approaches investigated in the paper is presented, including
the introduction of a robust joint model with time-varying degrees-of-freedom. Section 4 presents a simulation study comparing
the approaches assuming an underlying structure of time-varying degrees-of-freedom. Analysis of the two motivating examples
is presented in Section 5 followed by discussions in Section 6.
2 MOTIVATING EXAMPLES
2.1 NI Renal data
Recent renal research has shown the potential for patients’ haemoglobin (Hb) levels as an emerging biomarker for chronic kidney
disease15. It is known within the renal research that in the initial stages after commencing haemodialysis, patients’ haemoglobin
levels tend to fluctuate to a large degree and is deterimental to their survival. This research aims to capture and model these
initial stages of variability where there is a greater potential for patients to either have outlying observations from their own
trends over time or be an outlier themselves from the population.
This work will analyse data that has been collected from seven different renal centres by the NI Renal Information Service.
The NI renal data-set contains longitudinal information on 1,339 patients who have undergone haemodialysis treatment between
April 2002 and July 20114,10,16. In total, 27,064 Hb measurements were recorded, with a median of 14 observations per indi-
vidual. Other health related measurements, including creatinine and urea levels, were additionally monitored. Individuals were
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observed for a minimum of 2 days, and a maximum of approximately 9 years throughout the study follow-up period. 44% of the
patients died during the study period with the remaining patients being right-censored.
Figures 1 and 2 show the tail behaviour of the standardised conditional residuals and random-effects, respectively, based on a
joint model fitted for the NI renal data with Gaussian assumptions for both random-effects and error terms. Degrees-of-freedom
estimates for Figure 1 were obtained by fitting a univariate 푡 distribution such that 푡(휇, 휎, 휈), where 휇 is the location parameter,
휎 the scale, 휈 the degrees-of-freedom. Time (in years) was divided into bins based on 20% percentiles of the follow-up time.
As illustrated by Figures 1 and 2, there are departures from Normality for both random-effects and error terms. Figure 1 further
indicates that the degrees-of-freedom parameter of the 푡-distribution for the residuals varies over time, an anticipated result
based on the known impact on patients’ Hb levels initially as they adjust to the commencement of haemodialysis treatment. Such
changes over time will be accounted for through the time-varying degrees-of-freedom formulation introduced in Section 3.4.
2.2 Primary biliary cirrhosis (PBC) data
A second motivating example arises from data collected from 312 patients with primary biliary cirrhosis (PBC), a rare autoim-
mune disease which results in cirrhosis of the liver and fatality. Patients suffering from PBC produce increased levels of alkaline
in the blood. The PBC data-set was collected from the Mayo Clinic trial conducted between 1974 and 1984, which aimed to
assess the effectiveness of the D-penicillamine drug17. Of the 312 patients, 158 were randomly assigned to the drug, and 154 to
placebo. Median baseline age was 48.8 (minimum = 26.28, maximum = 78.44). In total, 1,885 repeated alkaline observations
were collected over the 10 year trial period, with a median of 5 (minimum = 1, maximum = 16) observations per individ-
ual. Individuals were observed for a minimum of 0.1 years, and a maximum of 14.3 years. 140 (45%) patients died during the
study-period.
The quantile-quantile plot for the standardised conditional residuals under the joint model with Gaussian assumption (left
panel of Figure 3) indicates heavier tails than Gaussian. Estimated degrees-of-freedom from univariate t distributions fitted to
residuals that fall into bins based on 20% percentiles of follow-up time indicate time-varying degrees-of-freedom structure up
to some extent. Figure 4 indicates that normality may be a reasonable assumption for the random effects.
3 APPROACHES FOR ROBUST JOINT MODELLING
3.1 Notation
Before introducing the models, we present the general notation used thoughout the paper. Let 푌푖푗 denote the 푗 th (푗 = 1,… , 푚푖)
repeated measurement belonging to subject 푖 (푖 = 1,… , 푛) collected at time 푡푖푗 , 푡푖 = {푡푖1,… , 푡푖푚푖} the set of the follow-up timesat which 푌푖푗’s are collected, 푎푖 = {푎푖1… 푎1푙} baseline covariate information, and 푆푖 survival time. Here, 푆푖 is subject to right-
censoring. Hence, we introduce an additional random variable, 퐸푖, defined by 퐸푖 = 퐼(푆∗푖 ≤ 퐶푖), where 퐼(⋅) being indicatorfunction, 푆∗푖 true survival time for subject 푖, 퐶푖 censoring time for the subject. 퐶푖 is defined as 퐶푖 = min(퐶,퐷푖), with 퐶 is thestudy end-time and 퐷푖 is the drop-out time for subject 푖.
3.2 Joint modelling of longitudinal and survival data
The framework for the so-called joint models for longitudinal and survival data under the shared-parameter paradigm is given by
푌푖푗 = 푌 ∗푖 (푡푖푗) +푍푖푗 ,
= 풙⊤푖푗휶 + 풅
⊤
푖푗푩푖 +푍푖푗 , (1)
ℎ푖(푡) = ℎ0(푡) exp
(
풄⊤푖 흎 + 푓 (∗푖 (푡); 휼)) . (2)
The framework allows for biomarker values (the longitudinal data) to be measured with error, i.e. the observed data, 푌푖푗 , is
composed of underlying continuous-time signal at time 푡푖푗 , 푌 ∗푖 (푡푖푗), and noise,푍푖푗 . The signal is de-composed into fixed-effects,
풙⊤푖푗휶, and random-effects, 풅⊤푖푗푩푖. Here, 풙푖푗 is a 푝×1matrix structured by 푎푖 and 푡푖. 휶 is a 푝×1matrix of regression coefficients asin multiple linear regression. 풅푖푗 is a 푞×1matrix, that is typically a subset of 풙푖푗 .푩푖 are subject-specific coefficients that take into
account heterogeneity between subjects. ℎ푖(푡) is the hazard of survival event for subject 푖 at time 푡. ℎ0(푡) is the baseline hazard
that can be specified using hazard functions of parametric distributions, e.g. Weibull; left un-specified as in Cox 18 ; assumed to
be piece-wise constant; or be expressed in terms of splines, e.g. natural cubic or B-splines. 풄푖 is a 푔 × 1 matrix with elements
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from 푎푖, 흎 푔 × 1 vector of regression coefficients. 푓 (∗푖 (푡); 휼) is the term for taking into account the association between hazardof survival event and features of biomarker process, with 푓 (⋅) being a known function. A popular choice is to use the current
value parametrisation such that 푓 (∗푖 (푡); 휼) = 휂푌 ∗푖 (푡). For other choices, see Hickey et al. 19 .The classical model assumptions for the random-effects and error components are zero-mean Gaussian distributions such that
퐁푖 ∼ (ퟎ,횺) ,
푍푖푗 ∼ (0, 휎2) ,
퐁푖 ⟂ 푍푖푗 , 푍푖푗 ⟂ 푍푖푗′ for 푗 ≠ 푗′,
where 횺 is the covariance matrix of the random-effects, and 휎 is the standard deviation of the measurement error. In what
follows, we extend the assumptions beyond the Gaussian.
3.3 Robust joint modelling
The robustness of the joint model will be determined by the distributions of the mixing variables, 퐁푖 and 푍푖푗 . The tail of the
density for 퐁푖 determines robustness against 푏-outliers and the tail of the density for 푍푖푗 determines the robustness against 푒-
outliers. We consider symmetric robust distributions for both the random-effects and error components through normal-variance
mixtures such that
퐁푖 = 횺1∕2
√
푉 퐵푖 퐁
∗
푖 ,
푍푖푗 = 휎
√
푉 푍푖푗 푍
∗
푖푗 ,
where퐁∗푖 ∼ (ퟎ, 퐈푞×푞) and푍∗푖푗 ∼ (0, 1). This formulation is flexible and includes widely used distributions as special cases20.The tail behaviour is determined by the distribution of 푉 퐵푖 and 푉 푍푖푗 . The special case 푉 퐵푖 = 1 and 푉 푍푖푗 = 1 recovers the Gaussianjoint model (see Section 3.2). In this study, we specifically consider inverse Gamma distribution  with equal shape and scale
parameters for the 푉 terms which results a t-distribution.
Ideally, one can use the posterior distribution of 푉 퐵푖 or 푉 푍푖푗 to detect outliers. If the posterior distribution of 푉 퐵푖 (푉 푍푖푗 ) isconcentrated at large values this should indicate a 푏-outlier for subject 푖 (푒-outlier for observation 푗 of patient 푖). However, in
much of the robust modelling literature dependence between 푉 퐵푖 and 푉 푍푖푗 , e.g. see21, and 푉 푍푖푗 and 푉 푍푖푗′ , e.g. Baghfalaki, Ganjaliand Berridge 9 , have been introduced (mainly to simplify the inferential procedure). These dependencies, hovewer, make the
aforementioned interpretation on outlier detection impossible.
In what follows, we will set three robust joint model formulations that are available in the literature and discuss implications.
3.3.1 Approach 1
McCrink 10 considered
푉 퐵푖 = 푉푖,
푉 푍푖푗 = 푉푖,
푉푖 ∼(훾∕2, 훾∕2).
The mixing variable is equal for both random-effects and error components. This implies that 푏- and 푒-outliers must be present
simultaneously for a subject, which would be a strong assumption. Note that under this assumption 퐁푖 and 퐙푖 = [푍푖1…푍푖푚푖]⊤will be jointly multivariate 푡 with a single degrees-of-freedom parameter, and the following properties do not hold: 퐁푖 ⟂ 푍푖푗 ,
and 푍푖푗 ⟂ 푍푖푗′ for 푗 ≠ 푗′.
3.3.2 Approach 2
Baghfalaki, Ganjali and Berridge 9 considered a robust joint model by setting
푉 퐵푖 = 푉
퐵
푖 ∼ (휙∕2, 휙∕2),
푉 푍푖푗 = 푉
푍
푖 ∼ (훿∕2, 훿∕2).
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Under this approach, 퐁푖 and 퐙푖 will be multivariate 푡, with separate degrees-of-freedom parameters; the property of 퐁푖 ⟂ 푍푖푗
holds, whereas 푍푖푗 ⟂ 푍푖푗′ for 푗 ≠ 푗′ does not. As 푍푖푗 and 푍푖푗′ for 푗 ≠ 푗′ share a common 푉 푍푖 , this approach can be seen as arandom-effects approach on the variance of 푍. This approach forces all the elements of {푍푖푗 ∶ 푗 = 1,… , 푚푖} to be outliers.
3.3.3 Approach 3
Asar, Fournier and Dantan 11 considered the setting of
푉 퐵푖 = 푉
퐵
푖 ∼ (휙∕2, 휙∕2),
푉 푍푖푗 = 푉
푍
푖푗 ∼ (훿∕2, 훿∕2),
for joint modelling. Under this approach the dependence between푍푖푗 and푍푖푗′ that was present in Approach 2 has been removed.
This is the most natural approach compared to the previous two, and will be used as a base for our time varying degrees-of-
freedom formulation.
3.4 Appoach 4: Time-varying degrees-of-freedom formulation
By building on Approach 3, we consider time-varying degrees-of-freedom parameter, 훿(푡), for 푍푖푗 . In practice, we need to
discretise time, i.e. 훿(푡) = 훿(푡푖푗). This approach considers
푉 푍푖푗 ∼ (훿푖푗∕2, 훿푖푗∕2),
훿푖푗 = exp(훿0 + 풂⊤푖푗휷).
Here, 풂푖푗 is a 푠 × 1 to be specified by natural cubic splines or B-splines, 휷 associated coefficients. Note that one obtains time
invariant degrees-of-freedom as 훿푖푗 = 훿 = exp(훿0), when 휷 = ퟎ.
3.5 Priors
We only give details about the prior distributions that are assigned to the parameters based on Approach 4, since Approaches
1-3 are just special cases. We set weakly-informative prior distributions for the parameters. Elements of 훼 are assigned zero-
mean Cauchy prior with scale of 5, (0, 5), only 훼0 was given (0, 20). 횺 is re-written as 퐑훀퐑, with 퐑 being a diagonal matrix
of scale parameters of 퐵ℎ (ℎ = 1,… , 푞), and 훀 a correlation matrix22. Elements of 퐑 are given half-Cauchy, +(0, 5), whereas
elements of훀 are given LKJ with the parameter of 2,  (2). Degrees-of-freedom parameter for 퐁푖, 휙, and 훿0 of푍푖푗 are given
uniform priors, between 2 and 100. Elements of 훃 are given (0, 5). 휎 is given +(0, 5). Log-transformed elements of ℎ0(푡) and
elements of 훚 and 훈 are given (0, 5).
3.6 Inference
For inference, we use Markov Chain Monte Carlo methods to sample from the joint posterior densities of the parameters and
latent variables given data. We specifically consider the Hamiltonian Monte Carlo (HMC)23 as implemented in the No-U-Turn
Sampler (NUTS)24. We do not present the details of neither the likelihood function, nor HMC and NUTS, since, whereas the
former is quite straightforward (e.g. see11), the second can be followed from the cited references.
Bespoke R25 codes to fit the joint models under Approaches 1-4 are available from the robjm package
(https://github.com/ozgurasarstat/robjm) that internally uses the HMC sampling engine Stan26 through the R
package Rstan27.
4 SIMULATION STUDY
A simulation study was conducted to investigate the effects of time-varying degrees-of-freedom in the estimation of parameters
for the joint modelling approaches discussed in Section 3. A sample size of 푛 = 250 individuals was considered with 200
data-sets being simulated under the assumption of time-varying degrees-of-freedom for the longitudinal residuals. Note that we
consider 200 as the number of replications mainly because of the computational cost.
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Data were generated under Approach 4. The assumed underlying structure for the time-varying degrees-of-freedom is
illustrated in Figure 5. The longitudinal sub-model was given by:
푌푖푗 = 푌 ∗푖 (푡푖푗) +푍푖푗 ,
= 훼1 + 푡푖푗훼2 + 퐵1푖 + 푡푖푗퐵2푖 +푍푖푗 , (3)
where each individual has an average of 20 observations between time points 0 and 5. A random-intercept (훼1+퐵1푖) and random-
slope (훼2 + 퐵2푖) model was assumed to replicate what is most commonly used in the joint modelling literature. Survival data
was generated from the following model:
ℎ푖(푡) = ℎ0(푡) exp
(
푋푖휔 + 푌 ∗푖 (푡)휂
)
, (4)
where 푋 ∼ Bernoulli(0.5), ℎ0(푡) specified by a Weibull baseline hazard, i.e. ℎ0(푡) = 휆휈푡휈−1. There is a final truncation time of
5 after which non-informative right-censoring occurs. The true values for the unknown parameters are given in Table 1.
Each robust model and the model with Gaussian assumptions for 퐁푖 and 푍푖푗 , called the standard joint model, were estimated
utilising the robjm package with four chains each of length 2,000 with the first 1000 iterations considered as warm-up. The
averages of posterior means, width of the corresponding 95% credibility intervals (CI) and coverage (Cov.) of 200 replications
for each model are collated in Table 1.
For all the models, including the standard joint model, fixed effects for both the longitudinal and survival models and baseline
hazard parameters demonstrate similar biases and coverages. In terms of averages of the credibility intervals for 훼1 and 훼2, the
standard joint model produces larger values compared to the other models. Coverages for the elements of 횺 are lower than
expected for the standard joint model, and almost 0 for Approach 1, whereas they are at the expected level for Approaches 2, 3
and 4. Approaches 1 and 2 produces biased and 0 coverage results for 휎2. This highlights the need to remove the dependence
between 푍푖푗 and 푍푖푗′ . Approach 3 provides similar estimates and levels of coverage compared to Approach 4. Therefore, whilst
Approach 3 has the inability to fully capture the time-varying nature of the degrees-of-freedom for the residuals, this appears to
have limited impact on the estimation of the other parameters.
5 ILLUSTRATIVE DATA EXAMPLES
5.1 Renal Example
The first case-study considers NI haemodialysis patients’ data with a joint model specified as:
푌푖푗 = 푌푖(푡푖푗) +푍푖푗 ,
= 훼1 + 푡푖푗훼2 + age푖훼3 + creatinine푖푗훼4 +MCHC푖푗훼5 +MCV푖푗훼6 + urea푖푗훼7
+male푖훼8 + I(EPO푖푗=Aranesp)훼9 + I(EPO푖푗=Alfa)훼10 + I(EPO푖푗=Other)훼11
+Prior2007푖훼12 + IronHydroxide푖푗훼13 + Venofer푖푗훼14 + 퐵1푖 + 푡푖푗퐵2푖 +푍푖푗 (5)
ℎ푖(푡) = ℎ0(푡) exp
(age푖휔 + 푌 ∗푖 (푡)휂) , (6)
where the response 푌 is an individual’s Hb level, ℎ0(푡) is assumed to be Weibull baseline hazard, MCHC represents mean
corpuscular haemoglobin concentration, MCV represents mean corpuscular volume and EPO represents erythropoietin drug
treatments.
The models were fitted using the robjm package with four chains each of length 8,000 with the first 2,000 iterations consid-
ered as warm-up. Posterior summaries for each of the approaches are given within Table 2. Convergence was confirmed using
traceplots and R-hat statistics28.
Similar to the findings of the simulation study in Section 4, in general, results based on Approaches 3 and 4 are quite similar.
There are differences in the results of these two models and the others, some parameters were overestimated whereas some were
underestimated. For example, the association parameter, 휂, appears to be affected by the choice of model. It is underestimated by
the standard joint model, which was overcome by Approach 1 up to some extent. Smoothed density plots for 휂 are displayed in
the left panel of Figure 6. Posterior summaries of degrees-of-freedom for Approach 3 and Approach 4 with 7 knots are displayed
in the right panel of Figure 6.
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5.2 PBC Example
The second case-study uses data from the PBC study. The model we fit has the following form:
푌푖푗 = 푌 ∗푖 (푡푖푗) +푍푖푗
= 훼1 + age푖훼2 + 푡푖푗훼3 + I(drug푖 = D-penicillamine)훼4 + 퐵푖1 + 푡푖푗퐵푖2 +푍푖푗 , (7)
ℎ푖(푡) = ℎ0(푡) exp
(age푖휔1 + I(drug푖 = D-penicillamine)휔2 + 푌 ∗푖 (푡)휂) , (8)
where 푌 = log(alkaline), age is baseline age, 푡 follow-up time, ℎ0(푡)Weibull baseline hazard function.
For Approaches 2–4, the results for 휙 indicated that Normal assumption might be reasonable for 퐁푖. Therefore, only 푍 term
was assumed to be 푡-distributed. For Approach 4, we considered number of knots ranging from 1 to 5. The knots were put into
the empirical quantiles of the time variable. Four chains, each length of 6,000, were started from random initials. Half of each
chain was considered as warm-up. Convergence was checked through traceplots and R-hat statistics28. Posterior summaries,
specifically the 2.5%, 50% and 97.5% percentiles, are displayed in Table 3.
The association parameter, 휂, seems to be affected by the model choice. Regarding model comparisons in terms of parameter
estimates, similar observations to those made for the NI renal application were observed for this case-study. The smoothed
densities of the MCMC samples of 휂 and the degrees-of-freedom estimates for Approach 3 and Approach 4 with 1 knot are
displayed in the left and right panels of Figure 7, respectively.
R codes to run the models for the PBC data could be reach at https://github.com/ozgurasarstat/robjm/blob/
master/tests/testthat/test_pbc_analysis.R.
6 DISCUSSION
This work introduces a new flexible approach to model longitudinal outliers in a joint modelling framework, where the degrees-
of-freedom parameter for the residuals is assumed to vary over time. This scenario replicates the common situation when patients
take time to adjust to new treatments, resulting in more outlying measurements (e-outliers) at different times across the period of
observation. In addition, this paper contrasts the new time-varying approach with three alternative time-invariant formulations
of robust joint models currently found in the literature and the standard joint model with Gaussian assumptions for the random
terms. Each of the approaches presented can be fitted in the accompanying robjm software package.
Throughout the results presented within the simulation study and the real-life data analysis, the need to properly account for
longitudinal outliers is evident, a practice not widely adopted in the current joint modelling literature. This paper highlights the
need to investigate the presence of outliers and provides a flexible approach to downweighing their negative impact, contrasting
the effect of various assumptions made by the different approaches to robust joint modelling. It is evident that bias and ineffi-
ciency results from ignorance of longitudinal outliers and the assumption of normality for the random terms. In addition, this
work highlights the need to remove the restrictive assumptions of Approaches 1 and 2.
Unexpectedly, despite a true underlying assumption of time-varying degrees-of-freedom within the simulation study,
Approach 3 was found to be in good agreement with the time-varying model. Within the simulation study and in the two real-life
examples, the degrees-of-freedom were assumed or estimated to be consistently low and varying over a limited range through-
out the period of observation. Under such scenarios, Approach 3 appears to provide a time-invariant average of the time-varying
degrees-of-freedom for the residuals over the period of observation, as demonstrated within Figure 6 for the renal analysis.
Given the limited change in estimated parameters between the two approaches, it is not therefore unexpected to find high levels
of agreement when comparing the posterior summaries of the predictions for the longitudinal random effects, as illustrated in
Figure 8 from the PBC analysis.
This work highlights the robustness provided by Approach 3 in the estimation of the degrees-of-freedom, providing similar
estimates as the time-varying approach inspite of the presence of time-varying degrees-of-freedom. It signifies that in cases
where the degrees-of-freedom parameter does not vary widely, Approach 3 is recommended when longitudinal outliers are
present.
We did not consider model selection methods to select the number of knots, mainly because the number of knots does not
seem to change the results considerably. In the time-varying degrees-of-freedommodel we assumed the scale parameter, 휎 being
time-constant. This parameter might also be assumed to be time-varying.
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FIGURE 1 Plots to inspect tail behavior of the standardised conditional residuals obtained from the joint model with Gaussian
assumptions for the renal dataset. Details of calculations are provided within Section 2.1. Left: Quantile-quantile plot against
standard Normal distribution; Right: Degrees-of-freedom parameter estimates.
FIGURE 2 Plots to inspect the distributions of the random-intercept (left) and random-slope (right) terms against standard
Normal based on the renal data.
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FIGURE 3 Plots to inspect the standardised conditional residuals obtained from the joint model with Gaussian assumptions
for the PBC data-set. Left: Quantile-quantile plot against standard Normal distribution, Right: degrees-of-freedom parameter
estimates. Degrees-of-freedom are obtained similar to Figure 1.
FIGURE 4 Plots to inspect the distributions of the random-intercept (left) and random-slope (right) terms against standard
Normal.
FIGURE 5 Underlying degrees-of-freedom assumption for simulation study.
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FIGURE 6 Left panel: Posterior densities of 휂 under different models. Right panel: Medians of degrees-of-freedom parameters
(mid-lines) and 2.5% and 97.5% percentiles of the MCMC samples under Approach 3 (solid) and time-varying model with 7
knots (dashed) based on NI renal data.
FIGURE 7 Left panel: smoothed MCMC samples of 휂 under different models. Right panel: Medians of degrees-of-freedom
parameters (mid-lines) and 2.5% and 97.5% percentiles of the MCMC samples under model 3 and tv model with 1 knot.
14 McFetridge ET AL
FIGURE 8 Posterior summaries (2.5%, 50% and 97.5% percentiles of the MCMC samples) for Approach 3 against the time-
varying model with 5 knots from the PBC analysis for the predictions of the longitudinal random intercept (top row) and slope
(bottom row).
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TABLE 2 Posterior summaries of the joint model parameters fitted to the NI renal dataset. Values in the upper rows for each
parameter are the 50% percentiles, whereas the brackets in the lower rows are the 2.5% and 97.5% percentiles, respectively.
nor-nor tt-mod1 tt-mod2 tt-mod3 tv-2knot tv-3knot tv-4knot tv-5knot tv-6knot tv-7knot
훼1
10.138 10.239 10.261 10.246 10.245 10.248 10.247 10.251 10.249 10.250
(10.018, 10.259) (10.117, 10.354) (10.145, 10.376) (10.133, 10.361) (10.130, 10.357) (10.132, 10.360) (10.134, 10.360) (10.135, 10.364) (10.132, 10.364) (10.136, 10.365)
훼2
-0.133 -0.138 -0.130 -0.127 -0.126 -0.127 -0.126 -0.126 -0.126 -0.126
(-0.163, -0.103) (-0.167, -0.110) (-0.157, -0.103) (-0.154, -0.100) (-0.154, -0.099) (-0.154, -0.099) (-0.154, -0.099) (-0.154, -0.099) (-0.154, -0.099) (-0.154, -0.099)
훼3
0.124 0.112 0.104 0.104 0.105 0.105 0.105 0.105 0.105 0.105
(0.089, 0.159) (0.077, 0.147) (0.071, 0.136) (0.073, 0.137) (0.073, 0.138) (0.073, 0.137) (0.073, 0.137) (0.072, 0.137) (0.073, 0.138) (0.073, 0.138)
훼4
0.138 0.125 0.123 0.127 0.128 0.128 0.128 0.128 0.128 0.128
(0.121, 0.154) (0.109, 0.142) (0.107, 0.140) (0.111, 0.144) (0.111, 0.145) (0.111, 0.144) (0.112, 0.144) (0.111, 0.144) (0.111, 0.144) (0.111, 0.145)
훼5
0.257 0.259 0.257 0.259 0.259 0.259 0.259 0.259 0.259 0.258
(0.239, 0.275) (0.242, 0.276) (0.240, 0.274) (0.241, 0.276) (0.241, 0.276) (0.241, 0.276) (0.241, 0.276) (0.241, 0.276) (0.241, 0.276) (0.241, 0.276)
훼6
0.265 0.290 0.281 0.274 0.277 0.277 0.277 0.277 0.276 0.276
(0.222, 0.308) (0.245, 0.334) (0.238, 0.325) (0.231, 0.318) (0.234, 0.320) (0.234, 0.321) (0.233, 0.319) (0.233, 0.320) (0.233, 0.320) (0.232, 0.320)
훼7
0.097 0.102 0.101 0.109 0.110 0.109 0.110 0.110 0.109 0.109
(0.075, 0.120) (0.080, 0.125) (0.079, 0.123) (0.087, 0.132) (0.087, 0.132) (0.087, 0.132) (0.087, 0.132) (0.087, 0.132) (0.087, 0.131) (0.087, 0.132)
훼8
-0.155 -0.142 -0.178 -0.187 -0.187 -0.190 -0.190 -0.191 -0.191 -0.191
(-0.255, -0.055) (-0.238, -0.045) (-0.270, -0.082) (-0.281, -0.095) (-0.279, -0.095) (-0.280, -0.100) (-0.280, -0.097) (-0.282, -0.098) (-0.282, -0.099) (-0.282, -0.100)
훼9
0.207 0.187 0.176 0.195 0.193 0.193 0.192 0.192 0.191 0.191
(0.136, 0.278) (0.117, 0.257) (0.107, 0.243) (0.125, 0.261) (0.124, 0.261) (0.125, 0.263) (0.123, 0.261) (0.124, 0.258) (0.123, 0.261) (0.122, 0.258)
훼10
-0.037 -0.062 -0.064 -0.053 -0.051 -0.051 -0.050 -0.051 -0.052 -0.052
(-0.147, 0.074) (-0.171, 0.045) (-0.170, 0.041) (-0.161, 0.054) (-0.160, 0.054) (-0.158, 0.055) (-0.157, 0.057) (-0.157, 0.054) (-0.160, 0.055) (-0.158, 0.057)
훼11
-0.100 -0.140 -0.152 -0.119 -0.131 -0.130 -0.130 -0.135 -0.139 -0.140
(-0.342, 0.151) (-0.381, 0.099) (-0.385, 0.089) (-0.346, 0.101) (-0.357, 0.092) (-0.357, 0.096) (-0.356, 0.093) (-0.364, 0.088) (-0.366, 0.087) (-0.364, 0.089)
훼12
0.348 0.333 0.331 0.325 0.324 0.324 0.324 0.322 0.323 0.323
(0.246, 0.451) (0.236, 0.433) (0.239, 0.426) (0.231, 0.419) (0.230, 0.417) (0.231, 0.418) (0.228, 0.418) (0.206, 0.419) (0.228, 0.417) (0.230, 0.419)
훼13
0.329 0.292 0.282 0.310 0.310 0.310 0.311 0.311 0.311 0.311
(0.271, 0.388) (0.236, 0.348) (0.227, 0.337) (0.255, 0.367) (0.254, 0.366) (0.254, 0.367) (0.254, 0.367) (0.254, 0.367) (0.255, 0.367) (0.254, 0.368)
훼14
0.241 0.223 0.218 0.221 0.221 0.221 0.221 0.220 0.220 0.220
(0.201, 0.282) (0.185, 0.261) (0.180, 0.255) (0.182, 0.260) (0.182, 0.259) (0.182, 0.260) (0.182, 0.260) (0.179, 0.259) (0.181, 0.259) (0.182, 0.259)
Σ11
1.043 0.901 0.551 0.543 0.540 0.538 0.539 0.534 0.536 0.536
(0.940, 1.158) (0.806, 1.005) (0.452, 0.664) (0.452, 0.648) (0.448, 0.644) (0.445, 0.640) (0.446, 0.644) (0.442, 0.638) (0.447, 0.638) (0.444, 0.643)
Σ12
-0.256 -0.218 -0.136 -0.140 -0.138 -0.137 -0.137 -0.136 -0.137 -0.137
(-0.303, -0.213) (-0.258, -0.182) (-0.172, -0.108) (-0.175, -0.110) (-0.173, -0.108) (-0.171, -0.107) (-0.173, -0.108) (-0.171, -0.107) (-0.170, -0.108) (-0.172, -0.107)
Σ22
0.134 0.113 0.075 0.080 0.078 0.078 0.077 0.076 0.077 0.077
(0.111, 0.162) (0.094, 0.138) (0.059, 0.095) (0.063, 0.101) (0.061, 0.098) (0.061, 0.097) (0.061, 0.098) (0.060, 0.097) (0.061, 0.097) (0.061, 0.098)
휎2
1.260 1.010 0.969 0.894 0.894 0.894 0.895 0.897 0.895 0.897
(1.238, 1.283) (0.972, 1.048) (0.931, 1.008) (0.866, 0.925) (0.865, 0.925) (0.866, 0.925) (0.866, 0.926) (0.868, 0.925) (0.866, 0.926) (0.866, 0.928)
훾 — 8.685 — — — — — — — —(7.708, 9.802)
휙 — — 3.150 2.764 2.760 2.742 2.751 2.727 2.726 2.727(2.504, 4.132) (2.280, 3.419) (2.273, 3.407) (2.263, 3.382) (2.283, 3.417) (2.244, 3.364) (2.261, 3.370) (2.256, 3.392)
훿 — — 7.789 6.847 — — — — — —(6.908, 8.804) (6.296, 7.561)
훿0 — — — — 5.532 5.071 4.671 4.894 4.554 4.355(4.722, 6.600) (4.167, 6.250) (3.782, 5.911) (3.874, 6.338) (3.553, 6.016) (3.347, 5.833)
훽1 — — — — 0.609 0.277 0.212 0.501 0.336 0.261(0.272, 0.957) (0.041, 0.513) (-0.056, 0.489) (0.182, 0.833) (-0.032, 0.695) (-0.122, 0.652)
훽2 — — — — 0.089 0.704 0.589 0.044 0.546 0.694(-0.346, 0.529) (0.333, 1.097) (0.258, 0.921) (-0.348, 0.435) (0.106, 0.984) (0.234, 1.178)
훽3 — — — — -0.865 0.281 0.432 0.781 0.129 0.233(-1.363, -0.328) (-0.249, 0.830) (0.006, 0.858) (0.447, 1.115) (-0.263, 0.513) (-0.181, 0.667)
훽4 — — — — — -0.991 0.468 0.165 0.983 0.542(-1.548, -0.379) (-0.165, 1.074) (-0.288, 0.619) (0.600, 1.396) (0.086, 0.984)
훽5 — — — — — — -0.812 0.198 -0.049 0.939(-1.407, -0.162) (-0.483, 0.879) (-0.548, 0.459) (0.526 ,1.340)
훽6 — — — — — — — -0.526 0.399 -0.004(-1.156, 0.204) (-0.317, 1.132) (-0.516, 0.499)
훽7 — — — — — — — — -0.358 0.524(-1.052, 0.442) (-0.230, 1.263)
훽8 — — — — — — — — — -0.411(-1.138, 0.390)
휆
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